Cargando…
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes
The development of therapeutic approaches based on direct cardiac reprogramming of fibroblasts into induced-cardiomyocytes (iCM) has emerged as an attractive strategy to repair the injured myocardium. The identification of the mechanisms driving lineage conversion represents a crucial step toward th...
Autores principales: | Testa, Gianluca, Russo, Michele, Di Benedetto, Giorgia, Barbato, Matteo, Parisi, Silvia, Pirozzi, Flora, Tocchetti, Carlo Gabriele, Abete, Pasquale, Bonaduce, Domenico, Russo, Tommaso, Passaro, Fabiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189257/ https://www.ncbi.nlm.nih.gov/pubmed/32346096 http://dx.doi.org/10.1038/s41598-020-63992-8 |
Ejemplares similares
-
Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed
por: Passaro, Fabiana, et al.
Publicado: (2017) -
YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
por: Di Benedetto, Giorgia, et al.
Publicado: (2021) -
Implications of Cellular Aging in Cardiac Reprogramming
por: Passaro, Fabiana, et al.
Publicado: (2018) -
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
por: Bolomsky, Arnold, et al.
Publicado: (2016) -
Advanced Technologies to Target Cardiac Cell Fate Plasticity for Heart Regeneration
por: Testa, Gianluca, et al.
Publicado: (2021)